BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22144831)

  • 21. Comparison of staining of mitotic figures by haematoxylin and eosin-and crystal violet stains, in oral epithelial dysplasia and squamous cell carcinoma.
    Ankle MR; Kale AD; Charantimath S
    Indian J Dent Res; 2007; 18(3):101-5. PubMed ID: 17687171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies.
    Abdalla Z; Walsh T; Thakker N; Ward CM
    PLoS One; 2017; 12(12):e0187449. PubMed ID: 29216196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
    Upadhyay J; Rao NN; Upadhyay RB
    J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
    Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
    Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
    Zhou J; Tao D; Xu Q; Gao Z; Tang D
    Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
    Chandolia B; Rajliwal JP; Bajpai M; Arora M
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of ctokeratins in the early detection of oral squamous cell carcinoma.
    Ali AA; Al-Jandan BA; Suresh CS
    J Oral Maxillofac Pathol; 2018; 22(3):441. PubMed ID: 30651696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of epithelial growth factor receptor in oral epithelial dysplastic lesions.
    Rajeswari MR; Saraswathi TR
    J Oral Maxillofac Pathol; 2012 May; 16(2):183-8. PubMed ID: 22923888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen deposition correlates with loss of E-cadherin and increased p63 expression in dysplastic conditions of oral submucous fibrosis.
    Chakraborti S; Paul RR; Pal M; Chatterjee J; Das RK
    Med Mol Morphol; 2022 Mar; 55(1):20-26. PubMed ID: 34482436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of keratin 19 expression in normal, metaplastic, condylomatous, atrophic, dysplastic, and malignant cervical squamous epithelium.
    Mittal KR; Demopoulos RI; Goswami S
    Am J Clin Pathol; 1992 Oct; 98(4):419-23. PubMed ID: 1384306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
    Tilakaratne WM; Kobayashi T; Ida-Yonemochi H; Swelam W; Yamazaki M; Mikami T; Alvarado CG; Shahidul AM; Maruyama S; Cheng J; Saku T
    J Oral Pathol Med; 2009 Apr; 38(4):348-55. PubMed ID: 19239574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of histological grade and expression of Ki67 protein in oral squamous cell carcinoma in young and old patients.
    Deyhimi P; Torabinia N; Torabinia A
    Dent Res J (Isfahan); 2013 Jul; 10(4):514-7. PubMed ID: 24130588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunohistochemical study of basement membrane heparan sulfate proteoglycan (perlecan) in oral epithelial dysplasia and squamous cell carcinoma.
    Mishra M; Chandavarkar V; Naik VV; Kale AD
    J Oral Maxillofac Pathol; 2013 Jan; 17(1):31-5. PubMed ID: 23798826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
    Kerdpon D; Rich AM; Reade PC
    Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma.
    Marshall DD; Kornberg LJ
    Laryngoscope; 1998 Sep; 108(9):1413-7. PubMed ID: 9738769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bax protein expression in the carcinogenesis of human oral mucosa].
    Zeng X; Chen Q; Li B; Tan N
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia.
    Cunningham LL; Pagano GM; Li M; Tandon R; Holm SW; White DK; Lele SM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):77-81. PubMed ID: 16831676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A qualitative and quantitative estimation of AgNORS in dysplastic and non-dysplastic leukoplakias.
    Pandit S; Aithal D
    Indian J Dent Res; 2002; 13(1):27-30. PubMed ID: 12420565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin B and D expression in squamous cell carcinoma.
    Kawada A; Hara K; Kominami E; Kobayashi T; Hiruma M; Ishibashi A
    Br J Dermatol; 1996 Dec; 135(6):905-10. PubMed ID: 8977710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.